Fig. 8: NALT1 may serve as a promising prognostic biomarker for CRC.
From: LncRNA NALT1 promotes colorectal cancer progression via targeting PEG10 by sponging microRNA-574-5p
A–E Predictive value of NALT1 tissue expression in clinicopathological features based on the CRC cohort (n = 76). F Tissue expression of NALT1 was associated with that of PEG10 in the CRC cohort (n = 76). Mean ± SD. Student’s t test or ANOVA. *p < 0.05; ns not significant. G Patients with rectum adenocarcinoma with high PEG10 expression survived shorter than those with low PEG10 expression in the GEPIA database. H The expression of NALT1 was associated with that of PEG10 in the CRC cohort in the GEPIA database.
